Stock Research for GILD


Featured Broker: Ally Invest

Get the due diligence for another stock.


GILD Stock Chart & Research Data

The GILD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GILD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


GILD Due diligence Resources & Stock Charts

The GILD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View GILD Detailed Price Forecast - CNN Money CNN View GILD Detailed Summary - Google Finance
Yahoo View GILD Detailed Summary - Yahoo! Finance Zacks View GILD Stock Research & Analysis -

Stock Analysis

TradeIdeas View GILD Trends & Analysis - Trade-Ideas Barrons View GILD Major Holders - Barrons
NASDAQ View GILD Call Transcripts - NASDAQ Seeking View GILD Breaking News & Analysis - Seeking Alpha
Spotlight View GILD Annual Report - OTC Report View GILD OTC Short Report -
TradeKing View GILD Fundamentals - TradeKing Charts View GILD SEC Filings - Bar Chart
WSJ View Historical Prices for GILD - The WSJ Morningstar View Performance/Total Return for GILD - Morningstar
MarketWatch View the Analyst Estimates for GILD - MarketWatch CNBC View the Earnings History for GILD - CNBC
StockMarketWatch View the GILD Earnings - StockMarketWatch MacroAxis View GILD Buy or Sell Recommendations - MacroAxis
Bullish View the GILD Bullish Patterns - American Bulls Short Pains View GILD Short Pain Metrics -

Social Media Mentions

StockTwits View GILD Stock Mentions - StockTwits PennyStocks View GILD Stock Mentions - PennyStockTweets
Twitter View GILD Stock Mentions - Twitter Invest Hub View GILD Investment Forum News - Investor Hub
Yahoo View GILD Stock Mentions - Yahoo! Message Board Seeking Alpha View GILD Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for GILD - Insider Cow View Insider Transactions for GILD - Insider Cow
CNBC View GILD Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for GILD - OTC Markets
Yahoo View Insider Transactions for GILD - Yahoo! Finance NASDAQ View Institutional Holdings for GILD - NASDAQ

Stock Charts

FinViz View GILD Stock Insight & Charts - StockCharts View GILD Investment Charts -
BarChart View GILD Stock Overview & Charts - BarChart Trading View View GILD User Generated Charts - Trading View

Latest Financial News for GILD

Cramer's lightning round: I don't like Snap's ownership structure
Posted on Friday June 22, 2018

Jim Cramer shares his take on callers' favorite stocks at lightning speed, including a much debated social media play.

Gilead Sciences Inc (NASDAQ:GILD): Should The Recent Earnings Drop Worry You?
Posted on Thursday June 21, 2018

In this commentary, I will examine Gilead Sciences Inc’s (NASDAQ:GILD) latest earnings update (31 March 2018) and compare these figures against its performance over the past couple of years, asRead More...

3 Big Biotechs That Can Beat the Market
Posted on Thursday June 21, 2018

Trading well below their one-year highs, big biotech stocks look set for a rebound as their fundamentals are showing signs of improvement. More stable product pricing environments, earnings improvement and successful new drug trials, are just a few of the factors that could lead to a biotech rally in the second half of the year, with firms like Gilead Sciences Inc. ( GILD), Alexion Pharmaceuticals Inc. ( ALXN) and Vertex Pharmaceuticals Inc. ( VRTX) leading the charge.

2 High-Flying Biotech Stocks With Even More Room to Grow
Posted on Wednesday June 20, 2018

These two red-hot biotechs are showing no signs of slowing down.

Enter a stock symbol to view the stock details.